These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 3042938)

  • 1. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J; Sinaasappel M; Neijens HJ
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis.
    Brady MS; Rickard K; Yu PL; Eigen H
    J Am Diet Assoc; 1992 Jul; 92(7):813-7. PubMed ID: 1624649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J; Hoffmann D; Paul D; Hein J; Paditz E
    Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
    Costantini D; Padoan R; Curcio L; Giunta A
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S36-9. PubMed ID: 3404360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis.
    Kalnins D; Corey M; Ellis L; Durie PR; Pencharz PB
    J Pediatr; 2005 Apr; 146(4):489-93. PubMed ID: 15812451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
    Petersen W; Heilmann C; Garne S
    Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.